Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical TrialChuan Huan Chuah, Bai Han Ooi, Kok Soon Lee et al.|Clinical Infectious Diseases|2021Cited by 47
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in MalaysiaSu Lan Yang, Kalaiarasu M. Peariasamy, Adiratna Mat Ripen et al.|Emerging Microbes & Infections|2022Cited by 27
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in MalaysiaSu Lan Yang, Kalaiarasu M. Peariasamy, Adiratna Mat Ripen et al.|Zenodo (CERN European Organization for Nuclear Research)|2022Cited by 0